Dr. Ethan Shen is the Founder, Chairman, and CEO of JY BioMed and YD Biopharma. He holds a PhD in Translational Medicine from Academia Sinica and Taipei Medical University, and dual EMBA degrees from Fudan University and National Taiwan University. A licensed pharmacist and experienced biotech entrepreneur, Dr. Shen has led the development of innovative platforms in exosome therapy, immuno-oncology, and liquid biopsy diagnostics. He is also the founder of the Taiwan Chronic Disease Healthcare Association and has secured collaborations with companies such as Roche, Novartis, and Sandoz.

Education

• PhD in Translational Medicine, Academia Sinica and Taipei Medical University

• EMBA, Fudan University and National Taiwan University

• Graduate Certificate in Financial Research, City University of New York, Baruch College

• Bachelor of Pharmacy, Taipei Medical University.

Key skills

• Translational Medicine

• New Drug Development

• Medical-grade Health Product Development

• Financial Management